{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:11:50Z","timestamp":1789668710378,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study investigated patterns of care and oncological outcomes in patients with ipsilateral breast tumor events (IBTE) after prior breast-conserving surgery (BCS) treated with curative intent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study was conducted on IBTE patients treated in 2016\u20132017 at 34 Dutch hospitals. Patient and characteristics, along with treatment details were collected and descriptive statistics were used for analysis. Overall survival (OS), disease-free survival (DFS) and breast cancer-specific survival (BCSS) were evaluated by using Kaplan-Meier analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 486 IBTE patients, 75.1% were diagnosed more than 5 years after the primary tumor, 87.4% had invasive breast cancer, and 12.6% DCIS. Distinguishing true recurrences from second primaries was not possible. Among invasive IBTE, 70 (14.6%) had primary DCIS and 350 (72.8%) an invasive primary tumor. Most IBTEs (54.9%) were T1, grade II (46.5%), and ER\/PR+\/HER2\u2212 (61.7%). Seventy-two (14.8%) patients received neoadjuvant systemic therapy. Salvage mastectomy was performed in 435 (89.5%) patients, while 51 (10.5%) underwent repeat BCS; 60.8% of these received postoperative whole-breast re-irradiation. Among mastectomy patients, 411 (94.5%) had prior radiotherapy; 13.1% received repeat radiotherapy, either alone (24.1%) or with hyperthermia (75.9%). Adjuvant systemic therapy was administered to 64.9%. After a median follow-up of 37 months, 83 (17.4%) developed a subsequent event: 33 (39.8%) second IBTE, 9 regional recurrences, and 41 (49.4%) distant metastases. Three- and five-year OS was 89% and 72.5%, respectively. Three- and five-year DFS was 85.5% and 69.9%, respectively. Three- and five-year BCSS was 95.1% and 86%, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Salvage mastectomy was the predominant treatment for IBTE, although repeat BCS with re-irradiation is increasingly performed in selected low-risk patients. Survival outcomes were favorable. The study highlights the need for tumor re-assessment and emphasizes the variability in IBTE management, underscoring the need for standardized treatment guidelines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-026-20080-x","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:07:56Z","timestamp":1784290076000},"page":"9110-9120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patterns of Care and Follow-up of Patients with an Ipsilateral Breast Tumor Event After Breast-Conserving Surgery: A Multicenter Retrospective Cohort Study in the Netherlands"],"prefix":"10.1245","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1399-3801","authenticated-orcid":false,"given":"Lisca F.","family":"Wurfbain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Tiels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice J. C.","family":"van der Sangen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coco J. E. F.","family":"Walstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa C.","family":"van Maaren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit E. P. J.","family":"Vriens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Willemien. Menke-van der Houven","family":"van Oordt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanne G.","family":"Bloemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri C.","family":"Voogd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grard A. P.","family":"Nieuwenhuijzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desir\u00e9e H. J. G.","family":"van den Bongard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert-Jan","family":"Schipper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Dutch Snapshot Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Zeillemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. J. T.","family":"Luiten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Doeksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. T.","family":"Frakking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jeuriens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. A. P.","family":"Brokx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"de Widt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. M. D.","family":"Lemaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. B.","family":"Koppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. M. A. L.","family":"Klem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Truin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"van Beurden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Merkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. J.","family":"Vles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. J.","family":"Liefers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J.","family":"Maaskant-Braat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Straver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. E.","family":"Dassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. A.","family":"Gooiker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Schlooz-Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. E.","family":"Rutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. C.","family":"Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. H.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Aarts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Brookman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"de Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J.","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"van Dessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"van Bastelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Outmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. L.","family":"Postma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. A.","family":"Bargon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.den","family":"Besten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Verheuvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. C. M.","family":"Zeestraten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M. T. J.","family":"Raben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"van de Wetering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. C.","family":"Hagenaars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. M.","family":"van Roosendaal. L. Cornelissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Stokmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"van Bergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. P. G.ten","family":"Broek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J. P.","family":"van Uden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Schreurs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. F.","family":"Hardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. R.","family":"Dulfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"de Rooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"issue":"20","key":"20080_CR1","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1200\/JCO.19.02806","volume":"38","author":"TA Buchholz","year":"2020","unstructured":"Buchholz TA, Ali S, Hunt KK. Multidisciplinary management of locoregional recurrent breast cancer. J Clin Oncol. 2020;38(20):2321\u20138.","journal-title":"J Clin Oncol."},{"issue":"2","key":"20080_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1053\/ctrv.2000.0204","volume":"27","author":"M Clemons","year":"2001","unstructured":"Clemons M, Danson S, Hamilton T, Goss P. Locoregionally recurrent breast cancer: incidence, risk factors and survival. Cancer Treat Rev. 2001;27(2):67\u201382.","journal-title":"Cancer Treat Rev."},{"issue":"3","key":"20080_CR3","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin."},{"issue":"8","key":"20080_CR4","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.ejso.2019.02.008","volume":"45","author":"CJEF Walstra","year":"2019","unstructured":"Walstra CJEF, Schipper R-J, Poodt IGM, van Riet YE, Voogd AC, van der Sangen MJC, et al. Repeat breast-conserving therapy for ipsilateral breast cancer recurrence: a systematic review. Eur J Surg Oncol. 2019;45(8):1317\u201327.","journal-title":"Eur J Surg Oncol."},{"issue":"2","key":"20080_CR5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s10549-021-06154-2","volume":"187","author":"CJEF Walstra","year":"2021","unstructured":"Walstra CJEF, Schipper RJ, van Riet YE, van der Toorn PG, Smidt ML, Sangen M, et al. Repeat breast-conserving treatment of ipsilateral breast cancer recurrence: a nationwide survey amongst breast surgeons and radiation oncologists in the Netherlands. Breast Cancer Res Treat. 2021;187(2):499\u2013514.","journal-title":"Breast Cancer Res Treat."},{"issue":"5","key":"20080_CR6","first-page":"2191","volume":"24","author":"R Chow","year":"2016","unstructured":"Chow R, Pulenzas N, Zhang L, Ecclestone C, Leahey A, Hamer J, et al. Quality of life and symptom burden in patients with breast cancer treated with mastectomy and lumpectomy. Supp Care Cancer. 2016;24(5):2191\u20139.","journal-title":"Supp Care Cancer."},{"issue":"5","key":"20080_CR7","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.ijrobp.2023.06.075","volume":"117","author":"J-M Hannoun-Levi","year":"2023","unstructured":"Hannoun-Levi J-M, Gal J, Polgar C, Strnad V, Loessl K, Polat B, et al. Second conservative treatment for local recurrence breast cancer: a GEC-ESTRO Oncological Outcome and Prognostic Factor Analysis. Int J Radiat Oncol Biol Phys. 2023;117(5):1200\u201310.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"2","key":"20080_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10549-025-07779-3","volume":"213","author":"SSW Tse","year":"2025","unstructured":"Tse SSW, Hircock C, Karam I, Soliman H, Lee SF, Choi JI, et al. Repeat lumpectomy and external beam radiation therapy for ipsilateral breast cancer recurrence: a systematic review. Breast Cancer Res Treat. 2025;213(2):205\u201317.","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"20080_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/jamaoncol.2019.4320","volume":"6","author":"DW Arthur","year":"2020","unstructured":"Arthur DW, Winter KA, Kuerer HM, Haffty B, Cuttino L, Todor DA, et al. Effectiveness of breast-conserving surgery and 3-dimensional conformal partial breast reirradiation for recurrence of breast cancer in the ipsilateral breast: The NRG Oncology\/RTOG 1014 phase 2 clinical trial. JAMA Oncol. 2020;6(1):75\u201382.","journal-title":"JAMA Oncol."},{"issue":"2","key":"20080_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10549-025-07730-6","volume":"212","author":"JM Jasper","year":"2025","unstructured":"Jasper JM, Vora H, Kantor O, McGrath M, Bellon JR, Mittendorf EA, et al. Management of ipsilateral breast tumor recurrence after prior breast conservation therapy. Breast Cancer Res Treat. 2025;212(2):361\u20139.","journal-title":"Breast Cancer Res Treat."},{"key":"20080_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.radonc.2021.12.036","volume":"167","author":"A Bakker","year":"2022","unstructured":"Bakker A, Tello Valverde CP, van Tienhoven G, Kolff MW, Kok HP, Slotman BJ, et al. Post-operative re-irradiation with hyperthermia in locoregional breast cancer recurrence: temperature matters. Radiother Oncol. 2022;167:149\u201357.","journal-title":"Radiother Oncol."},{"issue":"5","key":"20080_CR12","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.ijrobp.2015.12.361","volume":"94","author":"NR Datta","year":"2016","unstructured":"Datta NR, Puric E, Klingbiel D, Gomez S, Bodis S. Hyperthermia and radiation therapy in locoregional recurrent breast cancers: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys. 2016;94(5):1073\u201387.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"7","key":"20080_CR13","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.ejso.2022.03.017","volume":"48","author":"JL Morgan","year":"2022","unstructured":"Morgan JL, Cheng V, Barry PA, Copson E, Cutress RI, Dave R, et al. The MARECA (National Study of Management of Breast Cancer Locoregional Recurrence and Oncological Outcomes) study: National practice questionnaire of United Kingdom multi-disciplinary decision making. Eur J Surg Oncol. 2022;48(7):1510\u20139.","journal-title":"Eur J Surg Oncol."},{"key":"20080_CR14","unstructured":"Moossdorff M, van Roozendaal LM, Strobbe LJ, Aebi S, Cameron DA, Dixon JM, et al. Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research. J Natl Cancer Inst. 2014;106(12)."},{"issue":"3","key":"20080_CR15","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s10549-020-06040-3","volume":"186","author":"M Moossdorff","year":"2021","unstructured":"Moossdorff M, Vane MLG, van Nijnatten TJA, van Maaren MC, Goorts B, Heuts EM, et al. Conditional local recurrence risk: the effect of event-free years in different subtypes of breast cancer. Breast Cancer Res Treat. 2021;186(3):863\u201370.","journal-title":"Breast Cancer Res Treat."},{"issue":"3","key":"20080_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/PAS.0000000000002351","volume":"49","author":"M Fern\u00e1ndez-Abad","year":"2025","unstructured":"Fern\u00e1ndez-Abad M, Caniego-Casas T, Carretero-Barrio I, Calderay-Dom\u00ednguez M, Saavedra C, Hardisson D, et al. Ipsilateral breast carcinoma recurrence: true recurrence or new primary? A clinicopathologic and molecular study. Am J Surg Pathol. 2025;49(3):294\u2013302.","journal-title":"Am J Surg Pathol."},{"issue":"2","key":"20080_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ijrobp.2010.05.063","volume":"81","author":"V Panet-Raymond","year":"2011","unstructured":"Panet-Raymond V, Truong PT, McDonald RE, Alexander C, Ross L, Ryhorchuk A, et al. True recurrence versus new primary: an analysis of ipsilateral breast tumor recurrences after breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2011;81(2):409\u201317.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"10","key":"20080_CR18","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1002\/cncr.10952","volume":"95","author":"E Huang","year":"2002","unstructured":"Huang E, Buchholz TA, Meric F, Krishnamurthy S, Mirza NQ, Ames FC, et al. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer. 2002;95(10):2059\u201367.","journal-title":"Cancer."},{"issue":"1","key":"20080_CR19","first-page":"19","volume":"29","author":"M Casparie","year":"2007","unstructured":"Casparie M, Tiebosch AT, Burger G, Blauwgeers H, van de Pol A, van Krieken JH, et al. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol. 2007;29(1):19\u201324.","journal-title":"Cell Oncol."},{"key":"20080_CR20","unstructured":"Federatie Medisch Specialisten. Richtlijn Borstkanker. https:\/\/richtlijnendatabase.nl\/richtlijn\/borstkanker\/startpagina_-_borstkanker.html."},{"issue":"9","key":"20080_CR21","doi-asserted-by":"publisher","first-page":"993","DOI":"10.5858\/arpa.2023-0950-SA","volume":"147","author":"AC Wolff","year":"2023","unstructured":"Wolff AC, Somerfield MR, Dowsett M, Hammond MEH, Hayes DF, McShane LM, et al. Human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med. 2023;147(9):993\u20131000.","journal-title":"Arch Pathol Lab Med."},{"issue":"9","key":"20080_CR22","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.ejso.2015.05.015","volume":"41","author":"M Moossdorff","year":"2015","unstructured":"Moossdorff M, Vugts G, Maaskant-Braat AJ, Strobbe LJ, Voogd AC, Smidt ML, et al. Contralateral lymph node recurrence in breast cancer: Regional event rather than distant metastatic disease. A systematic review of the literature. Eur J Surg Oncol. 2015;41(9):1128\u201336.","journal-title":"Eur J Surg Oncol."},{"issue":"5","key":"20080_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.109564","volume":"51","author":"C Walstra","year":"2025","unstructured":"Walstra C, Schipper RJ, Voogd AC, van der Sangen MJC, van Duin R, van Riet YE, et al. The role of (18)F-FDG PET\/CT in detecting synchronous regional and distant metastatic disease in patients with an in-breast tumour recurrence. Eur J Surg Oncol. 2025;51(5):109564.","journal-title":"Eur J Surg Oncol."},{"key":"20080_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ijsu.2015.08.084","volume":"23","author":"T Kolben","year":"2015","unstructured":"Kolben T, Schwarz TM, Goess C, Blume C, Degenhardt T, Engel J, et al. Surgical management of ipsilateral breast tumor recurrence. Int J Surg. 2015;23:141\u20136.","journal-title":"Int J Surg."},{"issue":"6","key":"20080_CR25","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s12282-013-0454-6","volume":"21","author":"M Ishitobi","year":"2014","unstructured":"Ishitobi M, Okumura Y, Nishimura R, Nakatsukasa K, Tanabe M, Yoshida A, et al. Repeat lumpectomy for ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery: the impact of radiotherapy on second IBTR. Breast Cancer. 2014;21(6):754\u201360.","journal-title":"Breast Cancer."},{"issue":"15","key":"20080_CR26","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1200\/JCO.2008.19.8424","volume":"27","author":"SJ Anderson","year":"2009","unstructured":"Anderson SJ, Wapnir I, Dignam JJ, Fisher B, Mamounas EP, Jeong JH, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol. 2009;27(15):2466\u201373.","journal-title":"J Clin Oncol."},{"issue":"5","key":"20080_CR27","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/bjs.11097","volume":"106","author":"IGM Poodt","year":"2019","unstructured":"Poodt IGM, Vugts G, Schipper RJ, Roumen RMH, Rutten HJT, Maaskant-Braat AJG, et al. Prognostic impact of repeat sentinel lymph node biopsy in patients with ipsilateral breast tumour recurrence. Br J Surg. 2019;106(5):574\u201385.","journal-title":"Br J Surg."},{"issue":"3","key":"20080_CR28","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10549-022-06654-9","volume":"194","author":"R Haarsma","year":"2022","unstructured":"Haarsma R, van Loevezijn AA, Donswijk ML, Scholten AN, Vrancken Peeters M, van Duijnhoven FH. Added value of repeat sentinel lymph node biopsy in FDG-PET\/CT node-negative patients with ipsilateral breast cancer recurrence. Breast Cancer Res Treat. 2022;194(3):617\u201327.","journal-title":"Breast Cancer Res Treat."},{"issue":"10","key":"20080_CR29","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/cncr.34708","volume":"129","author":"X Lu","year":"2023","unstructured":"Lu X, He M, Yu L, Gou Z. Is repeat sentinel lymph node biopsy possible for surgical axillary staging among patients with ipsilateral breast tumor recurrence? Cancer. 2023;129(10):1492\u2013501.","journal-title":"Cancer."},{"issue":"3","key":"20080_CR30","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10549-024-07340-8","volume":"206","author":"S Zhang","year":"2024","unstructured":"Zhang S, Yang H, Xu Y, Wang S. Do we need reshape rTNM staging system for ipsilateral breast tumor recurrence of breast cancer? A population-based, propensity score matched cohort study. Breast Cancer Res Treat. 2024;206(3):637\u201351.","journal-title":"Breast Cancer Res Treat."},{"issue":"2","key":"20080_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.clon.2017.11.004","volume":"30","author":"O Kaidar-Person","year":"2018","unstructured":"Kaidar-Person O, Oldenborg S, Poortmans P. Re-irradiation and hyperthermia in breast cancer. Clin Oncol. 2018;30(2):73\u201384.","journal-title":"Clin Oncol."},{"issue":"11","key":"20080_CR32","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1200\/JCO.2017.76.5719","volume":"36","author":"IL Wapnir","year":"2018","unstructured":"Wapnir IL, Price KN, Anderson SJ, Robidoux A, Mart\u00edn M, Nortier JWR, et al. Efficacy of chemotherapy for ER-negative and ER-positive isolated locoregional recurrence of breast cancer: final analysis of the CALOR trial. J Clin Oncol. 2018;36(11):1073\u20139.","journal-title":"J Clin Oncol."},{"issue":"2","key":"20080_CR33","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S1470-2045(13)70589-8","volume":"15","author":"S Aebi","year":"2014","unstructured":"Aebi S, Gelber S, Anderson SJ, L\u00e1ng I, Robidoux A, Mart\u00edn M, et al. Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial. Lancet Oncol. 2014;15(2):156\u201363.","journal-title":"Lancet Oncol."},{"key":"20080_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jss.2020.07.045","volume":"258","author":"Y Wu","year":"2021","unstructured":"Wu Y, Shi X, Li J, Wu G. Prognosis of surgical treatment after ipsilateral breast tumor recurrence. J Surg Res. 2021;258:23\u201337.","journal-title":"J Surg Res."},{"key":"20080_CR35","doi-asserted-by":"crossref","unstructured":"Wu HL, Lu YJ, Li JW, Wu SY, Chen XS, Liu GY. Prior local or systemic treatment: a predictive model could guide clinical decision-making for locoregional recurrent breast cancer. Front Oncol. 2022;11.","DOI":"10.3389\/fonc.2021.791995"},{"issue":"2","key":"20080_CR36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/ijc.31914","volume":"144","author":"MC van Maaren","year":"2019","unstructured":"van Maaren MC, de Munck L, Strobbe LJA, Sonke GS, Westenend PJ, Smidt ML, et al. Ten-year recurrence rates for breast cancer subtypes in the Netherlands: a large population-based study. Int J Cancer. 2019;144(2):263\u201372.","journal-title":"Int J Cancer."},{"issue":"8","key":"20080_CR37","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S1470-2045(21)00288-6","volume":"22","author":"Trastuzumab for early-stage","year":"2021","unstructured":"Trastuzumab for early-stage. HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials. Lancet Oncol. 2021;22(8):1139\u201350.","journal-title":"Lancet Oncol."},{"issue":"2","key":"20080_CR38","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10549-021-06472-5","volume":"192","author":"M Meegdes","year":"2022","unstructured":"Meegdes M, Ibragimova KIE, Lobbezoo DJA, Vriens IJH, Kooreman LFS, Erdkamp FLG, et al. The initial hormone receptor\/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry. Breast Cancer Res Treat. 2022;192(2):331\u201342.","journal-title":"Breast Cancer Res Treat."},{"issue":"6","key":"20080_CR39","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/jnci\/djx273","volume":"110","author":"W Schrijver","year":"2018","unstructured":"Schrijver W, Suijkerbuijk KPM, van Gils CH, van der Wall E, Moelans CB, van Diest PJ. Receptor conversion in distant breast cancer metastases: a systematic review and meta-analysis. J Natl Cancer Inst. 2018;110(6):568\u201380.","journal-title":"J Natl Cancer Inst."},{"issue":"6","key":"20080_CR40","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.ejso.2020.11.122","volume":"47","author":"MLG Vane","year":"2021","unstructured":"Vane MLG, Moossdorff M, van Maaren MC, van Kuijk SMJ, van Nijnatten TJA, van Roozendaal LM, et al. Conditional regional recurrence risk: the effect of event-free years in different subtypes of breast cancer. Eur J Surg Oncol. 2021;47(6):1292\u20138.","journal-title":"Eur J Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20080-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20080-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20080-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:52:13Z","timestamp":1789667533000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20080-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["20080"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20080-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"6 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}